Nevro Q3 2023 Gaap EPS $(0.65) Beats $(0.77) Estimate, Sales $103.86M Beat $96.46M Estimate
Portfolio Pulse from saritha@benzinga.com
Nevro Corp. reported Q3 2023 GAAP EPS of $(0.65), beating the estimate of $(0.77) by 15.58%. This is a 10.17% decrease from the same period last year. The company's quarterly sales were $103.86M, surpassing the estimate of $96.46M by 7.67%, and marking a 3.38% increase from the same period last year.
November 01, 2023 | 9:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Nevro's Q3 2023 results beat estimates on both EPS and sales, which could positively impact the stock in the short term.
Nevro's better-than-expected Q3 2023 results, with EPS and sales both beating estimates, could lead to increased investor confidence and a potential short-term boost in the stock price. The EPS beat the estimate by 15.58% and sales beat the estimate by 7.67%, indicating strong financial performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100